Home > Insider Trading > Filing (0001140361-19-016474)

Filing Details

Accession Number:: 0001140361-19-016474
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-10 17:09:47
Reporting Period:: 2019-09-06

Accepted Time:: 2019-09-10 17:09:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1081714	R Henry Kravis	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1081715	R George Roberts	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 2800 Sand Hill Road, Suite 200 Menlo Park CA 94025	No	No	No	No
1404912	Kkr & Co. Inc.	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472694	Kkr Management Llc	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472697	Ltd Gp Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1472698	L.p. Holdings Fund Kkr	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No
1743754	Kkr Group Holdings Corp.	C/O Kohlberg Kravis Roberts &Amp; Co. L.p. 9 West 57Th Street, Suite 4200 New York NY 10019	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-09-06	6,666,684	$97.41	29,300	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2019-09-06	29,300	$0.00	0	No	4	J	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	J	Indirect	See Footnotes

Footnotes

This amount represents the secondary public offering price per share of common stock of PRA Health Sciences, Inc., less the underwriting discount of $0.09 per share.
Securities are held by KKR PRA Investors L.P. KKR PRA Investors GP II LLC is the general partner of KKR PRA Investors L.P. KKR PRA Investors GP LLC is the sole member of KKR PRA Investors GP II LLC. KKR North America Fund XI L.P. is the sole member of KKR PRA Investors GP LLC. KKR Associates North America XI L.P. is the general partner of KKR North America Fund XI L.P. KKR North America XI Limited is the general partner of KKR Associates North America XI L.P. KKR Fund Holdings L.P. is the sole shareholder of KKR North America XI Limited. KKR Fund Holdings GP Limited is a general partner of KKR Fund Holdings L.P. KKR Group Holdings Corp. is a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited. KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR Management LLC is the sole holder of Class B common stock of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the designated members of KKR Management LLC.
Represents shares being distributed in-kind to KKR North America Fund XI L.P., which are being further distributed to KKR Associates North America XI L.P., which are being further distributed to KKR North America XI Limited, which are being further distributed to KKR Fund Holdings L.P., which are being distributed to one of its limited partners, and which are being further distributed ultimately to individuals who have indirect interest in such shares.
Each of the Reporting Persons (other than KKR PRA Investors L.P.), disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than KKR PRA Investors L.P.) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.